| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.60B | 11.10B | 10.28B | 10.11B | 9.79B | 10.42B |
| Gross Profit | 8.36B | 7.93B | 7.40B | 7.28B | 7.12B | 7.77B |
| EBITDA | 2.81B | 2.85B | 2.86B | 4.37B | -924.00M | 1.17B |
| Net Income | 2.04B | 2.03B | 1.98B | 2.77B | -1.27B | 13.61B |
Balance Sheet | ||||||
| Total Assets | 17.89B | 17.61B | 19.36B | 21.62B | 20.85B | 26.63B |
| Cash, Cash Equivalents and Short-Term Investments | 3.86B | 2.92B | 6.22B | 9.02B | 7.51B | 7.32B |
| Total Debt | 7.08B | 7.38B | 7.86B | 8.23B | 9.42B | 9.43B |
| Total Liabilities | 13.48B | 12.99B | 14.21B | 15.22B | 15.70B | 16.85B |
| Stockholders Equity | 4.41B | 4.62B | 5.16B | 6.40B | 5.15B | 9.78B |
Cash Flow | ||||||
| Free Cash Flow | 1.69B | 1.66B | 1.96B | 1.97B | 1.80B | 2.21B |
| Operating Cash Flow | 2.14B | 2.19B | 2.41B | 2.43B | 2.25B | 2.66B |
| Investing Cash Flow | 897.00M | 1.19B | 2.21B | 240.00M | 2.46B | 3.66B |
| Financing Cash Flow | -2.97B | -3.66B | -3.81B | -2.45B | -3.79B | -6.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $52.01B | 19.91 | 44.12% | 1.38% | 13.15% | 5.89% | |
73 Outperform | $54.49B | 29.59 | 14.24% | ― | 40.54% | 78.98% | |
71 Outperform | $85.06B | 52.55 | 29.58% | ― | 42.11% | -6.84% | |
67 Neutral | $43.21B | 13.78 | 6.15% | 3.37% | 12.13% | -67.45% | |
66 Neutral | $5.76B | 17.26 | -25.47% | ― | 1.78% | 75.71% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $28.24B | -32.38 | -3.67% | ― | 13.10% | -163.64% |